查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088892

心房中膈缺損症市場：2026-2032年全球市場預測（依產品類型、治療方法、年齡層、最終用戶及缺損類型分類）

Atrial Septal Defect Market by Product Type, Treatment Type, Age Group, End User, Defect Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心房中膈缺損症市場將成長至 71 億美元，複合年成長率為 7.53%。

主要市場統計數據
基準年 2025 42.7億美元
預計年份：2026年 45.8億美元
預測年份 2032 71億美元
複合年成長率 (%) 7.53%

心房中膈缺損症市場概覽

心房中膈缺損症（ASD）是最常見的先天性心臟疾病之一，在先天性心臟疾病文獻中，它一直被認為是導致非紫紺型心臟畸形的主要原因。先天性心臟疾病的總體發生率估計約為每千名新生兒中有8例。 ASD的治療方法包括胎兒和兒童循環系統、成人先天性心臟疾病計畫、心臟超音波圖、基於導管的結構性心臟介入治療、心臟手術以及對心率和肺血管功能的長期後續觀察。

人工智慧（AI）的累積影響

人工智慧 (AI) 正透過影像擷取輔助、心腔自動量化、工作流程優先排序和臨床決策支援等方式，開始影響心房中膈缺損症的治療。在心臟超音波圖，AI 工具有助於標準化右心房和右心室大小、分流相關重塑以及影像品質的測量。在這些領域中，不同檢查者之間的差異可能會影響轉診和後續觀察決策。

亞太地區、北美地區、歐洲地區、拉丁美洲地區以及中東和非洲地區的主要區域趨勢

在亞太地區，中國、印度、日本、韓國、澳洲和東南亞國協大規模的兒童人口、不斷完善的心臟超音波圖基礎設施以及快速成長的三級醫療機構支撐了對經導管房間隔缺損封堵術的需求。該地區心房中膈缺損症的治療路徑日益受到公立兒童心臟病計畫、私立醫院投資以及導管檢查室普及程度的影響，儘管遍遠地區的醫療服務可及性和成本效益仍然存在差異。北美地區經導管房間隔缺損封堵術的普及率仍然很高，這得益於美國和加拿大成熟的結構性心臟疾病項目、成人先天性心臟疾病網路、規範的醫療設備核准流程以及完善的保險報銷系統。

東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵集團分析

在東協市場，先天性心臟疾病的治療基礎設施正透過對公立醫院、私立心臟中心和區域轉診網路的投資而不斷完善，但新加坡、馬來西亞、泰國、印尼、越南和菲律賓等國之間的醫療服務可及性差異顯著。海灣合作理事會（GCC）國家優先發展專業的心臟醫療保健基礎設施、醫療旅遊和政府資助的醫療保健服務，這使得該地區成為房間隔缺損（ASD）醫療設備、影像系統和臨床醫生培訓計畫的重要戰略市場。

主要國家心房中膈缺損症（ASD）治療趨勢

美國在結構性心臟介入治療的臨床應用、成人先天性心臟疾病專科護理以及房間隔關閉計畫的先進影像技術方面處於主導。加拿大受益於其全民健保體系和完善的兒童心臟中心，而墨西哥和巴西儘管主要城市醫院的醫療服務可及性有所提高，但仍面臨著醫療設備成本高昂、保險報銷差異以及專科醫生短缺等挑戰。

為自閉症譜系障礙產業領導者提供的實用建議

行業領導者不應將封鎖手術定位為「一刀切」的治療方法，而應使其與循證醫學的患者選擇、解剖結構兼容性、生命週期隨訪和房間隔缺損（ASD）治療策略相一致。醫療設備開發商應致力於提高植入的便利性、取出的便利性、提供兒童尺寸選擇、影像相容性以及長期安全性證據；同時，醫院應加強多學科心臟團隊建設，團隊成員應包括兒童循環系統、成人先天性心臟疾病專家、介入性心臟病專家、外科醫生、麻醉師和影像專家。

調查方法

本執行摘要是基於對二手研究和證據的整合，這些研究和證據涵蓋了同行評審的先天性心臟疾病文獻、心臟病學會指南、公共衛生資訊來源、監管資料庫、醫院實踐以及醫療技術應用趨勢。主要參考領域包括先天性心臟疾病的流行病學、房間隔缺損的分類和治療路徑、經導管封堵術的證據、心臟超音波圖標準以及成人先天性心臟疾病的管理。

結論

心房中膈缺損症的治療正朝著早期發現、微創介入、數據驅動的後續觀察以及加強兒童和成人先天性心臟疾病醫療服務之間的合作方向發展。處於優勢地位的機構將整合成熟的醫療設備、專業的影像技術、臨床教育以及社區服務策略，以應對高所得國家和醫療資源匱乏地區的醫療保健體系。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：心房中膈缺損症市場：依產品類型分類

  • 心肺體外迴圈裝置
  • 封閉式設備
    • 封堵器
      • 球囊擴張型閉塞器
      • 自延伸式閉塞器
    • 外科補片
      • 生物衍生貼片
      • 合成貼片
  • 診斷設備
    • 心臟導管插入設備
    • 心臟影像系統
    • 心臟超音波圖系統

第8章：心房中膈缺損症市場：依治療方法分類

  • 介入治療
  • 非介入治療

第9章：心房中膈缺損症市場：依年齡層別分類

  • 成人
  • 兒童

第10章：心房中膈缺損症市場：依最終用戶分類

  • 門診手術中心
  • 心臟中心
  • 醫院

第11章：心房中膈缺損症市場：依缺損類型分類

  • 冠狀竇
  • 原發孔
  • 塞坎達姆
  • 靜脈竇

第12章：心房中膈缺損症市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：心房中膈缺損症市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：心房中膈缺損症市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Abbott Laboratories
  • Asklepion Pharmaceuticals, LLC
  • atHeart Medical AG
  • B. Braun Medical Inc.
  • Boston Scientific Corporation
  • Carag AG
  • Edwards Lifesciences
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd
  • Lifetech Scientific
  • Occlutech GmbH
  • Visionary Medtech Solutions
  • WL Gore & Associates, Inc.
  • Weigao Meidcal international Co., Ltd
Product Code: MRR-CA17E905E9C1

The Atrial Septal Defect Market is projected to grow by USD 7.10 billion at a CAGR of 7.53% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.27 billion
Estimated Year [2026] USD 4.58 billion
Forecast Year [2032] USD 7.10 billion
CAGR (%) 7.53%

Atrial Septal Defect Market Introduction

Atrial septal defect (ASD) is among the most common congenital heart defects, with published congenital heart disease literature consistently identifying ASD as a leading acyanotic lesion and estimating congenital heart disease overall at roughly 8 per 1,000 live births. ASD management spans fetal and pediatric cardiology, adult congenital heart disease programs, echocardiography, catheter-based structural heart intervention, cardiac surgery, and long-term rhythm and pulmonary vascular surveillance.

The atrial septal defect landscape is being shaped by earlier diagnosis, wider use of transthoracic and transesophageal echocardiography, increased adult detection, and strong clinical preference for minimally invasive closure when anatomy is suitable. Secundum ASD remains the principal target for transcatheter closure, while primum, sinus venosus, and complex defects continue to require specialist surgical assessment. Transformative Shifts in the ASD Landscape

The most important shift in atrial septal defect care is the movement from symptom-driven treatment to lifecycle management. Children diagnosed through screening and imaging can be followed before right heart dilation progresses, while adults increasingly enter care after incidental imaging, arrhythmia evaluation, stroke workup, or assessment of unexplained exercise intolerance.

Technology is also changing the treatment pathway. Contemporary occluder devices, improved delivery systems, 3D echocardiography, intracardiac echocardiography, and hybrid imaging have expanded the number of patients evaluated for catheter-based ASD closure. At the same time, guideline-based selection remains critical because pulmonary hypertension, deficient rims, associated anomalous pulmonary venous return, and non-secundum anatomy can shift care toward surgery or conservative management.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence atrial septal defect care through image acquisition support, automated chamber quantification, workflow triage, and clinical decision support. In echocardiography, AI-enabled tools can help standardize measurements of right atrial and right ventricular size, shunt-related remodeling, and image quality, areas where inter-operator variability can affect referral and follow-up decisions.

The cumulative impact of AI is likely to be highest when combined with expert review rather than used as a stand-alone diagnostic authority. Hospitals and medical technology developers are exploring AI for patient identification from electronic health records, procedural planning, post-closure surveillance, and registry analytics. Adoption will depend on validation across pediatric and adult populations, transparent algorithms, cybersecurity, regulatory clearance, and integration into congenital heart disease workflows.

Key Regional Insights Across Asia-Pacific, North America, Europe, Latin America, Middle East & Africa

In Asia-Pacific, demand is supported by large pediatric populations, expanding echocardiography capacity, and rapid growth of tertiary cardiac centers in China, India, Japan, South Korea, Australia, and ASEAN economies. The region's atrial septal defect care pathway is increasingly shaped by public-sector pediatric cardiac programs, private hospital investment, and broader availability of catheterization laboratories, although rural access and affordability remain uneven. North America remains a high-adoption region for transcatheter ASD closure because of mature structural heart programs, adult congenital heart disease networks, regulated medical device pathways, and strong reimbursement infrastructure in the United States and Canada.

Europe benefits from established congenital heart disease registries, evidence-based clinical guidelines, regulated medical technology pathways, and cross-border clinical expertise, particularly within Western Europe and the European Union. Latin America, led by Brazil and Mexico, shows improving access to pediatric cardiology and interventional cardiology, although cost sensitivity and uneven specialist distribution remain important constraints. The Middle East is investing in advanced cardiac centers across GCC markets, while Africa faces the greatest access gap, with late diagnosis, limited catheterization capacity, constrained specialist availability, and reliance on mission-based or public-sector cardiac surgery in many countries.

Key Group Insights Across ASEAN, GCC, European Union, BRICS, G7, and NATO

ASEAN markets are expanding congenital heart disease capacity through public hospital investment, private cardiac centers, and regional referral networks, although access varies significantly between Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines. GCC countries are prioritizing specialty cardiac infrastructure, medical tourism, and government-funded access, making the region strategically relevant for ASD devices, imaging systems, and clinician training programs.

The European Union offers a regulated, evidence-oriented environment for atrial septal defect diagnosis and closure, with emphasis on clinical outcomes, device safety, interoperability, and post-market surveillance. BRICS countries combine large patient pools with heterogeneous access, creating opportunities for value-based device strategies, local manufacturing alignment, training partnerships, and referral network development. G7 markets lead in advanced imaging, adult congenital care, structured reimbursement, and AI-enabled workflow adoption, while NATO member countries overlap substantially with high-income healthcare systems that emphasize cardiac readiness, specialty care access, resilient medical supply chains, and standardized procurement practices.

Key Country Insights for Atrial Septal Defect Care

The United States leads in structural heart intervention, adult congenital heart disease specialization, and clinical adoption of advanced imaging for ASD closure planning. Canada benefits from universal healthcare pathways and strong pediatric cardiac centers, while Mexico and Brazil show rising access in major urban hospitals but remain sensitive to device cost, reimbursement variability, and specialist availability.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain mature congenital cardiology ecosystems supported by specialist centers, echocardiography capacity, and guideline-based care, with Germany and France also contributing strongly to device evaluation and imaging innovation. Russia has specialized cardiac centers but faces procurement and regional access variability. In Asia-Pacific, China and India represent high-volume care needs driven by population scale and expanding cardiac infrastructure; Japan, South Korea, and Australia emphasize quality, regulatory rigor, advanced imaging-supported intervention, and structured follow-up for pediatric and adult congenital heart disease patients.

Actionable Recommendations for ASD Industry Leaders

Industry leaders should align ASD strategies with evidence-based patient selection, anatomical suitability, and lifecycle follow-up rather than positioning closure as a one-size-fits-all intervention. Medical device developers should invest in deliverability, retrievability, pediatric sizing options, imaging compatibility, and long-term safety evidence, while hospitals should strengthen multidisciplinary heart teams that include pediatric cardiologists, adult congenital specialists, interventionalists, surgeons, anesthesiologists, and imaging experts.

Commercial teams should prioritize physician education, echo-lab standardization, registry participation, and market access evidence that demonstrates reduced morbidity, shorter hospital stays, and durable closure outcomes where clinically appropriate. AI vendors should focus on validated use cases such as automated chamber measurement, patient triage, procedural workflow support, and follow-up adherence, supported by transparent performance data across age groups and diverse healthcare settings.

Research Methodology

This executive summary is built from secondary research and evidence synthesis across peer-reviewed congenital heart disease literature, cardiology society guidance, public health sources, regulatory databases, hospital practice patterns, and medical technology adoption trends. Key reference domains include epidemiology of congenital heart disease, ASD classification and treatment pathways, transcatheter closure evidence, echocardiography standards, and adult congenital heart disease management.

The methodology emphasizes triangulation rather than single-source interpretation. Regional, group, and country insights are assessed through healthcare infrastructure maturity, specialist availability, reimbursement environment, regulatory readiness, procedural capacity, and adoption of imaging, catheterization, and AI-enabled clinical workflows. Only data-backed and clinically accepted concepts are used; speculative market claims, company-level comparisons, market sizing, market share, and unverified numerical estimates are excluded.

Conclusion

Atrial septal defect care is moving toward earlier detection, minimally invasive intervention, data-driven follow-up, and stronger integration between pediatric and adult congenital heart disease services. The best-positioned organizations will combine proven devices, expert imaging, clinical education, and regional access strategies that address both high-income and underserved healthcare systems.

Artificial intelligence, advanced echocardiography, and improved occluder technology will enhance the ASD care pathway, but clinical judgment and guideline-based selection will remain central. Long-term progress in the atrial septal defect market will depend on safe closure outcomes, equitable access, reimbursement evidence, and the ability to identify untreated patients before complications such as right heart enlargement, arrhythmia, pulmonary hypertension, or paradoxical embolism develop.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Atrial Septal Defect Market, by Product Type

  • 7.1. Cardiopulmonary Bypass Devices
  • 7.2. Closure Devices
    • 7.2.1. Occluder Devices
      • 7.2.1.1. Balloon-Expandable Occluders
      • 7.2.1.2. Self-Expanding Occluders
    • 7.2.2. Surgical Patches
      • 7.2.2.1. Biologic Patches
      • 7.2.2.2. Synthetic Patches
  • 7.3. Diagnostic Devices
    • 7.3.1. Cardiac Catheterization Equipment
    • 7.3.2. Cardiac Imaging Systems
    • 7.3.3. Echocardiography Systems

8. Atrial Septal Defect Market, by Treatment Type

  • 8.1. Interventional Treatment
  • 8.2. Non-Interventional Treatment

9. Atrial Septal Defect Market, by Age Group

  • 9.1. Adult
  • 9.2. Pediatric

10. Atrial Septal Defect Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Centers
  • 10.3. Hospitals

11. Atrial Septal Defect Market, by Defect Type

  • 11.1. Coronary Sinus
  • 11.2. Ostium Primum
  • 11.3. Ostium Secundum
  • 11.4. Sinus Venosus

12. Atrial Septal Defect Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Atrial Septal Defect Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Atrial Septal Defect Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Abbott Laboratories
  • 16.2. Asklepion Pharmaceuticals, LLC
  • 16.3. atHeart Medical AG
  • 16.4. B. Braun Medical Inc.
  • 16.5. Boston Scientific Corporation
  • 16.6. Carag AG
  • 16.7. Edwards Lifesciences
  • 16.8. GE HealthCare Technologies, Inc.
  • 16.9. Koninklijke Philips N.V.
  • 16.10. Lepu Medical Technology (Beijing) Co., Ltd
  • 16.11. Lifetech Scientific
  • 16.12. Occlutech GmbH
  • 16.13. Visionary Medtech Solutions
  • 16.14. W. L. Gore & Associates, Inc.
  • 16.15. Weigao Meidcal international Co., Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATRIAL SEPTAL DEFECT MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ATRIAL SEPTAL DEFECT MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIOPULMONARY BYPASS DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOPULMONARY BYPASS DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOPULMONARY BYPASS DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL OCCLUDER DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OCCLUDER DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OCCLUDER DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BALLOON-EXPANDABLE OCCLUDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BALLOON-EXPANDABLE OCCLUDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BALLOON-EXPANDABLE OCCLUDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SELF-EXPANDING OCCLUDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SELF-EXPANDING OCCLUDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SELF-EXPANDING OCCLUDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGIC PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGIC PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGIC PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SYNTHETIC PATCHES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SYNTHETIC PATCHES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SYNTHETIC PATCHES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIAGNOSTIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIAC CATHETERIZATION EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIAC CATHETERIZATION EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIAC CATHETERIZATION EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIAC IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIAC IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIAC IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ECHOCARDIOGRAPHY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ECHOCARDIOGRAPHY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ECHOCARDIOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTERVENTIONAL TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTERVENTIONAL TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTERVENTIONAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-INTERVENTIONAL TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-INTERVENTIONAL TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-INTERVENTIONAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CORONARY SINUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CORONARY SINUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CORONARY SINUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OSTIUM PRIMUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL OSTIUM PRIMUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL OSTIUM PRIMUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OSTIUM SECUNDUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OSTIUM SECUNDUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OSTIUM SECUNDUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SINUS VENOSUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SINUS VENOSUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SINUS VENOSUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. G7 ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. NATO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 214. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 217. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 220. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 224. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 225. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 227. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 232. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 234. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 237. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 254. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 257. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 262. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 263. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 264. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 267. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 272. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 274. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 275. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 278. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 282. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 283. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 284. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 285. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 287. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 292. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 293. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 294. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 295. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 312. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 313. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 314. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 315. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 317. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 318. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 320. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 322. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 323. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 324. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 325. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 327. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 332. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 333. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 334. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 335. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 336. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 337. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 338. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 340. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 341. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY CLOSURE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 342. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY OCCLUDER DEVICES, 2018-2032 (USD MILLION)
  • TABLE 343. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SURGICAL PATCHES, 2018-2032 (USD MILLION)
  • TABLE 344. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2032 (USD MILLION)
  • TABLE 345. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 346. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 347. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 348. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY DEFECT TYPE, 2018-2032 (USD MILLION)